Literature DB >> 32730808

Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy.

Wei Wu1, Qiuping Zhou1, Takeya Masubuchi2, Xiaoshan Shi3, Hua Li1, Xinyi Xu1, Min Huang1, Li Meng1, Xing He1, Hengyu Zhu1, Shuaixin Gao4, Nan Zhang4, Ruirui Jing5, Jie Sun5, Haopeng Wang6, Enfu Hui7, Catherine Chiulan Wong8, Chenqi Xu9.   

Abstract

A T cell receptor (TCR) mediates antigen-induced signaling through its associated CD3ε, δ, γ, and ζ, but the contributions of different CD3 chains remain elusive. Using quantitative mass spectrometry, we simultaneously quantitated the phosphorylation of the immunoreceptor tyrosine-based activation motif (ITAM) of all CD3 chains upon TCR stimulation. A subpopulation of CD3ε ITAMs was mono-phosphorylated, owing to Lck kinase selectivity, and specifically recruited the inhibitory Csk kinase to attenuate TCR signaling, suggesting that TCR is a self-restrained signaling machinery containing both activating and inhibitory motifs. Moreover, we found that incorporation of the CD3ε cytoplasmic domain into a second-generation chimeric antigen receptor (CAR) improved antitumor activity of CAR-T cells. Mechanistically, the Csk-recruiting ITAM of CD3ε reduced CAR-T cytokine production whereas the basic residue rich sequence (BRS) of CD3ε promoted CAR-T persistence via p85 recruitment. Collectively, CD3ε is a built-in multifunctional signal tuner, and increasing CD3 diversity represents a strategy to design next-generation CAR.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CAR-T therapy; Csk; ITAM; T cell receptor; TCR; cancer; cell persistence; cytokine release; p85; phosphorylation pattern; quantitative mass spectrometry

Mesh:

Substances:

Year:  2020        PMID: 32730808     DOI: 10.1016/j.cell.2020.07.018

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  21 in total

Review 1.  Recent advances and discoveries in the mechanisms and functions of CAR T cells.

Authors:  Rebecca C Larson; Marcela V Maus
Journal:  Nat Rev Cancer       Date:  2021-01-22       Impact factor: 60.716

Review 2.  Role of inhibitory signaling in peripheral B cell tolerance.

Authors:  Andrew Getahun
Journal:  Immunol Rev       Date:  2022-02-06       Impact factor: 12.988

Review 3.  CAR T-cell immunotherapy: a powerful weapon for fighting hematological B-cell malignancies.

Authors:  Jian-Qing Mi; Jie Xu; Jianfeng Zhou; Weili Zhao; Zhu Chen; J Joseph Melenhorst; Saijuan Chen
Journal:  Front Med       Date:  2021-12-18       Impact factor: 4.592

4.  Spatial requirements for ITAM signaling in an intracellular natural killer cell model membrane.

Authors:  Gene Chong; Alexander D MacKerell
Journal:  Biochim Biophys Acta Gen Subj       Date:  2022-08-03       Impact factor: 4.117

5.  Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains.

Authors:  Khloe S Gordon; Taeyoon Kyung; Caleb R Perez; Patrick V Holec; Azucena Ramos; Angela Q Zhang; Yash Agarwal; Yunpeng Liu; Catherine E Koch; Alina Starchenko; Brian A Joughin; Douglas A Lauffenburger; Darrell J Irvine; Michael T Hemann; Michael E Birnbaum
Journal:  Nat Biomed Eng       Date:  2022-06-16       Impact factor: 29.234

Review 6.  Insights into intercellular receptor-ligand binding kinetics in cell communication.

Authors:  Chenyi An; Xiaohuan Wang; Fan Song; Jinglei Hu; Long Li
Journal:  Front Bioeng Biotechnol       Date:  2022-06-28

7.  CD276 suppresses CAR-T cell function by promoting tumor cell glycolysis in esophageal squamous cell carcinoma.

Authors:  Guangxing Yue; Jingwen Tang; Lihan Zhang; Hong Niu; Huahua Li; Suxia Luo
Journal:  J Gastrointest Oncol       Date:  2021-02

Review 8.  Genetic engineering of T cells for immunotherapy.

Authors:  Gavin I Ellis; Neil C Sheppard; James L Riley
Journal:  Nat Rev Genet       Date:  2021-02-18       Impact factor: 59.581

Review 9.  A narrative review of chimeric antigen receptor-T (CAR-T) cell therapy for lung cancer.

Authors:  Yujia Liu; Yayi He
Journal:  Ann Transl Med       Date:  2021-05

Review 10.  T Cell Activation Machinery: Form and Function in Natural and Engineered Immune Receptors.

Authors:  Nicholas J Chandler; Melissa J Call; Matthew E Call
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.